Intravenous Antibiotics: Where We Are and Where We’re Going – ß-lactams
Contact Hours: 2
Cost: $20.00
For a complete list of accreditations for this course, please see the accreditation information box below the author’s bio. All states (with the exception of Hawaii) recognize our courses for accredited continuing nursing education, CNE, contact hours.
This instructional course has been designed for nurses administering and/or caring for the patient receiving intravenous antibiotics. I.V. antibiotics have been administered for nearly a century but bacterial resistance has forced an ever-increasing arsenal of drugs. In this often- changing landscape, the nurse needs a working knowledge of the antimicrobial agents available, and competency to infuse these medications in all the various administration systems in use today. This course examines the medication family known as beta-lactam antibiotics, and the various classes of drugs within this family.
State Boards of Nursing have varying positions on the role of the LPN/LVN in the administration of infusion therapy, including the administration of antimicrobial agents. Competency requirements are obtained and maintained through the nurse’s employer, facility or institution. This course provides 2.00 contact hours of continuing education.
A link to each state board of nursing is
listed here.
Objectives
Upon completion of this curriculum, the nurse will be able to:
1. Identify at least two actions that have increased the incidence of antibiotic
resistance.
2. Describe the use of various intravenous antibiotic admixture containers
and delivery systems.
3. Identify the classifications of intravenous beta-lactam antibiotics and
medications belonging to each class.
Curriculum
Chapter 1: Introduction
•
Antibiotic resistance
•
Intravenous antibiotic administration systems
•
Clostridium difficile
Chapter 2: Penicillins
•
Penicillin G
•
Nacillin
•
Piperacillin
•
Ampicillin
•
Aztreonam – monobactam
Chapter 3: Cephalosporins
•
First through fifth generation
•
Indications
•
Administration
•
Side Effects
Chapter 4: Carbopenems
•
Imipenem/Cilastatin
•
Meropenem
•
Ertapenem
•
Dorapenem
Chapter 5: Antibiotic Stewardship
•
New antibiotic initiative
•
Phage therapy
•
Supplements